XML 40 R31.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity (Tables)

9 Months Ended

Dec. 31, 2021

Schedule of Stock Option and RSU and PSU Award Activities

The following table summarizes the Company’s stock option, restricted stock unit (“RSU”), and performance unit (“PSU”) award activities for the nine months ended December 31, 2021 (in thousands, except exercise price, contractual term and fair value information):


	Options Outstanding						RSUs Outstanding						PSUs Outstanding
	Number of Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value		Number of Shares	Weighted- Average Grant Date Fair Value		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value		Number of Shares	Weighted- Average Grant Date Fair Value		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding - April 1, 2021	2,718	$	50.55	6.2	$	48,064	3,293	$	67.76	2.8	$	202,459	112	$	99.05	2.0	$	6,884
Granted	—	—					2,407	69.59					241	82.89
Exercised/vested	(727)	40.14			32,092		(1,116)	66.51					(33)	99.05
Canceled/forfeited	(187)	71.30					(967)	66.45					—
Outstanding - December 31, 2021	1,804	$	52.59	5.7	$	103,913	3,617	$	69.70	2.8	$	399,108	320	$	86.88	2.0	$	35,235

Schedule of Stock-based Compensation Expense Attributed to Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses

Cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands):


	Three Months Ended December 31,				Nine Months Ended December 31,
	2021		2020		2021		2020
Cost of revenue	$	1,382	$	1,472	$	3,757	$	4,596
Research and development	13,117		10,960		36,228		30,214
Sales and marketing	12,537		15,115		37,619		42,960
General and administrative (1)	10,755		8,922		39,945		25,274
Total stock-based compensation expense (2)	$	37,791	$	36,469	$	117,549	$	103,044

(1) Includes $9.6 million acceleration of share-based payment expense for the nine months ended December 31, 2021, for one of the Company’s executives due to his departure at the end of June 2021. There was no corresponding expense for the three-month period.

(2) Includes $0.5 million expense for the nine months ended December 31, 2021, due to the restructuring activities commenced in the first quarter of fiscal 2022. There was no corresponding expense for the three-month period. Refer to Note 16. Restructuring for more information.